Latest news
25 items- SECNovan Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Material Modification to Rights of Security Holders8-K - NVN Liquidation, Inc. (0001467154) (Filer)
- SECNovan Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - NVN Liquidation, Inc. (0001467154) (Filer)
- SECNovan Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - NVN Liquidation, Inc. (0001467154) (Filer)
- SECNovan Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - NVN Liquidation, Inc. (0001467154) (Filer)
- SECNovan Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - NVN Liquidation, Inc. (0001467154) (Filer)
- SECNovan Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - NVN Liquidation, Inc. (0001467154) (Filer)
- SECNovan Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Leadership Update, Financial Statements and Exhibits8-K - Novan, Inc. (0001467154) (Filer)
- SECNovan Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits8-K - Novan, Inc. (0001467154) (Filer)
- SECNovan Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Novan, Inc. (0001467154) (Filer)
- SECSEC Form 25-NSE filed by Novan Inc.25-NSE - Novan, Inc. (0001467154) (Subject)
- SECNovan Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Novan, Inc. (0001467154) (Filer)
- SECNovan Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Novan, Inc. (0001467154) (Filer)
- PRLigand Reports Second Quarter 2023 Financial ResultsConference Call Begins at 4:30 p.m. Eastern Time Today Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today reported financial results for the three and six months ended June 30, 2023, and provided an operating forecast and business updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement and answer questions. "We are pleased to report continued momentum across our portfolio of partnered assets, with multiple positive developments for our commercial and pipeline products," said Todd Davis, CEO of Ligand. "Ligand has a strong balance sheet with $219 million in cash, and, after a recent paydown of convertible notes, w
- SECNovan Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Novan, Inc. (0001467154) (Filer)
- NEWSVerrica's Ycanth Unlikely to Face Near-Term Competition, Analyst Upgrades Stock On FDA ApprovalMonday, the FDA approved Verrica Pharmaceuticals Inc's (NASDAQ:VRCA) Ycanth (cantharidin) topical solution for molluscum contagiosum (molluscum) in adult and pediatric patients two years of age and older. Needham upgraded the stock to Buy from Hold with a price target of $10. Needham analysts Serge Belanger and Rohit Bhasin have commented that the approval of Ycanth signifies the reemergence of cantharidin, a blistering agent commonly used to treat warts. While it was previously only accessible through compounding pharmacies, cantharidin will now be reintroduced into dermatology practices as an FDA-approved product. The regulatory and financial uncertainties surrounding VRCA have been r
- NEWS12 Health Care Stocks Moving In Tuesday's Pre-Market SessionGainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock moved upwards by 45.4% to $5.03 during Tuesday's pre-market session. The company's market cap stands at $30.6 million. Enzo Biochem (NYSE:ENZ) shares rose 16.91% to $1.59. The market value of their outstanding shares is at $79.0 million. Aravive (NASDAQ:ARAV) shares moved upwards by 14.09% to $1.7. The market value of their outstanding shares is at $101.7 million. Novan (NASDAQ:NOVN) stock increased by 11.5% to $0.14. The market value of their outstanding shares is at $3.9 million. Biotricity (NASDAQ:BTCY) stock rose 10.72% to $3.51. The market value of their outstanding shares is at $30.7 million. Alpha Tau Medical (NASDAQ:DRTS) stock move
- NEWS12 Health Care Stocks Moving In Friday's Intraday SessionGainers Quoin Pharmaceuticals (NASDAQ:QNRX) stock moved upwards by 36.1% to $8.86 during Friday's regular session. As of 13:30 EST, Quoin Pharmaceuticals's stock is trading at a volume of 5.5 million, which is 27175.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.7 million. Fresh Tracks Therapeutics (NASDAQ:FRTX) stock rose 33.54% to $0.91. Trading volume for Fresh Tracks Therapeutics's stock is 24.9 million as of 13:30 EST. This is 8375.3% of its average full-day volume over the last 100 days. The company's market cap stands at $5.3 million. LifeMD (NASDAQ:LFMD) shares rose 26.34% to $4.46. As of 13:30 EST, this security is
- NEWSStocks That Hit 52-Week Lows On FridayOn Friday, 54 companies hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: NovoCure (NASDAQ:NVCR) is the largest company in terms of market cap to set a new 52-week low this morning. Ucommune International (NASDAQ:UK) was the smallest company by market cap to set a new 52-week low. Sigma Additive Solutions (NASDAQ:SASI) saw the largest move of the companies, as shares plummetted 27.56% to hit a new 52-week low. Greenbrook TMS (NASDAQ:GBNH) shares were the most resilient of the group, as shares actually moved up 0.0% in response to hitting its 52-week low. On Friday, the following stocks broke to new 52-week lows: NovoCure (NASDAQ:NVCR) stock achieved a new 52-
- NEWS12 Health Care Stocks Moving In Thursday's After-Market SessionGainers Evelo Biosciences (NASDAQ:EVLO) stock increased by 11.7% to $11.01 during Thursday's after-market session. Trading volume for this security closed at 524.2K, accounting for 68.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $206.8 million. TFF Pharmaceuticals (NASDAQ:TFFP) shares moved upwards by 9.28% to $0.4. The market value of their outstanding shares is at $14.5 million. Anitra (AMEX:AZTR) stock increased by 7.49% to $4.3. The market value of their outstanding shares is at $51.9 million. Intensity Therapeutics (NASDAQ:INTS) stock moved upwards by 6.74% to $6.49. The market value of their outstanding shares is at $8
- NEWS12 Health Care Stocks Moving In Wednesday's After-Market SessionGainers Dynatronics (NASDAQ:DYNT) stock moved upwards by 17.7% to $0.92 during Wednesday's after-market session. The market value of their outstanding shares is at $3.7 million. Novan (NASDAQ:NOVN) shares rose 9.99% to $0.2. Trading volume for this security closed at 4.6 million, accounting for 680.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.6 million. Trinity Biotech (NASDAQ:TRIB) shares moved upwards by 8.79% to $1.11. The company's market cap stands at $42.4 million. 9 Meters Biopharma (NASDAQ:NMTR) shares moved upwards by 8.32% to $0.18. 9 Meters Biopharma's trading volume hit 901.9K shares by close, accounting for 3
- NEWSWhy Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionGainers Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring. The Singing Machine Company, Inc. (NASDAQ:MICS) shares surged 32% to $2.10 after the company announced it launched a new party accessory product line available at Walmart. Biophytis S.A. (NASDAQ:BPTS) gained 29% to $2.78 after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's main product. iCAD, Inc. (NASDAQ:ICAD) rose 21.3% to $2.50. iCAD signed strategic commercial agreement with Radiology Partners, the nation's largest radiology practice. Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) s
- NEWSWhy Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving PremarketGainers Biophytis S.A. (NASDAQ:BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's main product. Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) shares gained 41.8% to $0.3729 in pre-market trading after EMA announced positive feedback on the company's proposed Phase 3 study AR-301 for pneumonia caused by Gram-positive bacteria Staphylococcus aureus in mechanically ventilated hospitalized patients. Karyopharm Therapeutics Inc. (NASDAQ:KPTI) rose 26.1% to $1.93 in pre-market trading after the company received FDA Fast Track Designation for Selinexor for Myelofibrosis. Rubicon
- SECNovan Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Novan, Inc. (0001467154) (Filer)
- NEWSCrude Oil Falls; GreenPower Motor Company Shares Spike HigherU.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 0.25% on Monday. The Dow traded up 0.25% to 34,596.04 while the NASDAQ rose 0.92% to 14,243.64. The S&P 500, also rose, gaining, 0.43% to 4,524.74. Check This Out: Baidu To Rally Around 32%? Here Are 10 Other Analyst Forecasts For Monday Leading and Lagging Sectors Financial shares climbed by 1.1% on Monday. In trading on Monday, utilities shares fell by 0.7%. Top Headline Guaranty Bancshares, Inc. (NYSE:GNTY) reported better-than-expected second-quarter financial results. Guaranty Bancshares posted quarterly earnings of 81 cents per share, topping market estimates of 56 cents per share. The company’s
- NEWS12 Health Care Stocks Moving In Monday's Intraday SessionGainers BridgeBio Pharma (NASDAQ:BBIO) shares rose 78.8% to $32.58 during Monday's regular session. The current volume of 37.7 million shares is 2024.4% of BridgeBio Pharma's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $5.2 billion. Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 62.89% to $10.23. Acumen Pharmaceuticals's stock is trading at a volume of 25.2 million shares as of 13:30 EST. This is 8337.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $419.6 million. Quantum-Si (NASDAQ:QSI) shares moved upwards by 33.91% to $3.24. The curre
NOVN FAQ
7 questionsWhat does Novan Inc. do?
Novan, Inc., a clinical development-stage biotechnology company, provides nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of...Where does NOVN stock trade?
Novan Inc. (NOVN) is listed on NASDAQ.What sector and industry is NOVN in?
Novan Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Novan Inc. go public?
Novan Inc. (NOVN) completed its IPO in 2016.What are analysts saying about NOVN?
Novan Inc. has had 2 recent analyst actions on file. The most recent action was from HC Wainwright & Co.: Buy with a $2400.00 price target on 2021-09-24. Recent price targets range from $2400.00 to $3000.00.What companies are similar to NOVN?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare NOVN side-by-side with any of them on Quantisnow.How can I track NOVN on Quantisnow?
Quantisnow aggregates Novan Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NOVN to receive live email and push alerts on every new disclosure.